EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Cord blood red cell concentrates for preterm neonate transfusion: Insights from the multicenter BORN trial

Claudio Pellegrino iD, Patrizia Papacci, Carlo Dani, Francesco Cresi, Giulia Remaschi iD, Giulia Ansaldi, Carmen Giannantonio, Maria Francesca Campagnoli, Barbara Vania, Marco Fabbri, Roberta Penta de Vera d' Aragona, Anna Molisso und 27 weitere

Transfusion · 2026-07 · 66 (7) · 1402-1414

DOI: 10.1111/trf.70241 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Transfusion, online erschienen am 29.04.2026. Verfasst von Claudio Pellegrino und 38 weiteren Autor:innen. Beteiligte Einrichtung: Fondazione Policlinico A. Gemelli IRCCS, Rome, Italy. Hauptthemen laut MEDLINE: Erythrocyte Transfusion, Fetal Blood, Infant, Premature, Erythrocytes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fresenius Kabi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The BORN trial suggested that using cord blood‐red blood cells (CB‐RBCs) to transfuse severely preterm neonates significantly improves clinical outcomes compared to standard adult donor RBCs (A‐RBC). Study Design and Methods The study illustrates CB‐RBC concentrate production and inventory management across nine CB banks participating in the BORN trial. Quality requirements were those established by the European regulation for leukocyte‐depleted RBC concentrates in additive solution. The compliance rate among centers was reported.

Results

During the BORN study, 451 CB‐RBC units were processed and 107 were transfused to 69 patients in the intervention arm. However, for 67 transfusion requests, no compatible CB‐RBC units were available and adult‐RBCs were given. The CB‐RBC inventory comprised a minor fraction of CB units collected during the study period, suggesting that many did not meet the protocol‐defined volume threshold of 67 mL at collection. Quality control results showed that 84.0% of units achieved target hematocrit (Htc) levels (50–70%), with higher success rates in centers processing more CB units. All centers met quality standards, maintaining residual leukocytes below 1 × 10 6 and end‐storage hemolysis below 0.8% in more than 90% of cases. CB‐RBC availability was significantly limited by the time required for bacterial testing results and the need for γ‐irradiation.

Discussion

These data suggest that the standardized CB‐RBC production is reproducible. Moreover, extending CB‐RBC storage to 21 days could maximize the inventory utility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Erythrocyte TransfusionFetal BloodInfant, PrematureErythrocytesHumansInfant, NewbornHematocritFemaleMaleBlood PreservationQuality Control

Stichwörter der Autor:innen

extremely low gestational age neonatesfetal hemoglobinrandomized controlled trialretinopathy of prematuritytransfusionsumbilical blood

Autor:innen und Institutionen

  • Fondazione Policlinico A. Gemelli IRCCS, Rome, Italy.
  • Università Cattolica del Sacro Cuore, Rome, Italy.
  • Azienda Ospedaliero Universitaria Careggi, Florence, Italy.
  • Città della Salute e della Scienza, Torino, Italy.
  • Department of Public Health and Pediatrics, Università di Torino, Torino, Italy.
  • Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.

ORCID-Profile: Claudio Pellegrino, Giulia Remaschi, Francesca Serrao, Daniele Prati, Caterina Giovanna Valentini, Luciana Teofili

Förderung

  • Fresenius Kabi

Zitieren

APA

Pellegrino, C., Papacci, P., Dani, C., Cresi, F., Remaschi, G., Ansaldi, G., Giannantonio, C., Campagnoli, M. F., Vania, B., Fabbri, M., Aragona, R. P. V., Molisso, A., Beccastrini, E., Dragonetti, A., Pasciuto, T., Gabbriellini, S., Baroni, S., Serrao, F., Purcaro, V., …, & Teofili, L. (2026). Cord blood red cell concentrates for preterm neonate transfusion: Insights from the multicenter BORN trial. Transfusion, 66(7), 1402-1414. https://doi.org/10.1111/trf.70241

Vancouver

Pellegrino C, Papacci P, Dani C, Cresi F, Remaschi G, Ansaldi G, et al. Cord blood red cell concentrates for preterm neonate transfusion: Insights from the multicenter BORN trial. Transfusion. 2026;66(7):1402-1414. doi:10.1111/trf.70241

BibTeX
@article{Pellegrino2026,
  author = {Pellegrino, Claudio and Papacci, Patrizia and Dani, Carlo and Cresi, Francesco and Remaschi, Giulia and Ansaldi, Giulia and Giannantonio, Carmen and Campagnoli, Maria Francesca and Vania, Barbara and Fabbri, Marco and Aragona, Roberta Penta de Vera d' and Molisso, Anna and Beccastrini, Enrico and Dragonetti, Antonella and Pasciuto, Tina and Gabbriellini, Sabrina and Baroni, Silvia and Serrao, Francesca and Purcaro, Velia and Raffaeli, Genny and Villa, Stefania and Prati, Daniele and Mondello, Isabella and Falcone, Alessandra and Patti, Maria Letizia and Boggini, Tiziana and Bergamaschi, Paola and Mozzetta, Iolanda and Valentini, Caterina Giovanna and Locatelli, Emanuela and Albiani, Roberto and Besso, Federico Genzano and Cantone, Giulia Vanina and Coscia, Alessandra and Trimarchi, Alfonso and Capone, Anita and Ghirardello, Stefano and Vento, Giovanni and Teofili, Luciana},
  title = {Cord blood red cell concentrates for preterm neonate transfusion: Insights from the multicenter BORN trial},
  journal = {Transfusion},
  year = {2026},
  volume = {66},
  number = {7},
  pages = {1402--1414},
  doi = {10.1111/trf.70241}
}
Kostenlos starten →